أثر تطبيق اتفاقية تريبس على براءة الاختراع الدوائية
Other Title(s)
The application of the Trips agreement on the pharmaceutical patent
Author
Source
Issue
Vol. 11, Issue 2 (30 Jun. 2019), pp.668-677, 10 p.
Publisher
Ziane Achour University of Djelfa
Publication Date
2019-06-30
Country of Publication
Algeria
No. of Pages
10
Main Subjects
Abstract EN
Developed countries sought to globalize the protection of their innovations within the framework of a multilateral trading system under the umbrella of the World Trade Organization (WTO) through the TRIPS Agreement.
This protection extended to the pharmaceutical industries through patent protection for 20 years, In addition to extending protection to both product and method.
This has negatively affected developing countries by acquiring the knowledge and innovations of developed countries in this sector by restricting the possibilities of manufacturing drugs for twenty years, which results in higher prices of these drugs and the monopoly of the major pharmaceutical companies in the pharmaceutical
American Psychological Association (APA)
قراش، شريفة. 2019. أثر تطبيق اتفاقية تريبس على براءة الاختراع الدوائية. دراسات و أبحاث،مج. 11، ع. 2، ص ص. 668-677.
https://search.emarefa.net/detail/BIM-894050
Modern Language Association (MLA)
قراش، شريفة. أثر تطبيق اتفاقية تريبس على براءة الاختراع الدوائية. دراسات و أبحاث مج. 11، ع. 2 (حزيران 2019)، ص ص. 668-677.
https://search.emarefa.net/detail/BIM-894050
American Medical Association (AMA)
قراش، شريفة. أثر تطبيق اتفاقية تريبس على براءة الاختراع الدوائية. دراسات و أبحاث. 2019. مج. 11، ع. 2، ص ص. 668-677.
https://search.emarefa.net/detail/BIM-894050
Data Type
Journal Articles
Language
Arabic
Notes
يتضمن هوامش : ص. 676-677
Record ID
BIM-894050